Valuation models
price $92.40 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused65.25 – 93.0076.6521% overvaluedDCF · Perpetuity growth · 10y74.67 – 105.4687.356% overvaluedDCF · EBITDA exit · 5y142.80 – 155.74149.1038% undervaluedDCF · EBITDA exit · 10y137.00 – 160.75148.3038% undervaluedP/E · peers79.23 – 142.94109.3215% undervaluedP/E · own history163.97 – 230.23191.9352% undervaluedPEG—85.997% overvaluedEV/EBITDA · peers95.41 – 128.65108.6715% undervaluedEV/Revenue · peers90.24 – 146.95117.4621% undervaluedEarnings power value31.30 – 45.5337.18149% overvaluedDividend discount26.67 – 63.8538.87138% overvaluedWall St. consensus target—124.0025% belowCost of capital (WACC)—8.60%—
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
76.65
Xylem closed at $92.40 — overvalued by 21% vs model.
65.25the model's range93.00
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
37.18 – 191.93
Wall St. target
124.00 25% below
Above model, 1y
19 of 30 days
How it is valued
Valued asMature & Stable
Moderate growth (~11% recent)Moderate margins (11% net margin)Pays dividendsHighly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.